S&P 500 Pushes for 9th Straight Day of Gains, Eli Lilly Says Weight-Loss Drug Reduces Diabetes Risk

The stock market is buzzing with the S&P 500 pushing for a ninth consecutive day of gains, fueled by Nvidia's impressive performance. Eli Lilly’s new weight-loss drug shows promise in reducing diabetes risk, potentially reshaping healthcare. Meanwhile, Paramount's buyout saga and Palo Alto Networks’ earnings highlight the evolving landscape of corporate mergers and cybersecurity challenges. Boeing faces setbacks with its 777X tests, raising concerns over transparency with SEC scrutiny on Carl Icahn.